Retina implant device offers new hope for blind people

The Retina Implant developed by German medical technology company IIP Technologies, which is designed to restore a degree of sight to blind people suffering from certain retinal degenerations, has successfully been put through a clinical test. 19 out of 20 patients that took part in a study by four European clinics reported that visual perception had been triggered by electrical stimulation.

In the acute test involving patients suffering from retinitis pigmentosa, a section of the prosthesis (chip) developed by IIP was inserted into the eye for less than an hour to see whether and under what conditions visual perception could be triggered by electrical stimulation of the retina. This clinical test was the most significant study in the world so far for the systematic testing of this kind of retinal stimulation. The visual perceptions described by the patients and the stimulation parameters required to trigger these perceptions represent a good basis for the further development of a visual prosthesis that can be implanted permanently.

The relevant ethical committee has authorized a further clinical test with patients affected by macular degeneration. This test will be carried out over the next few months in collaboration with the University Eye Clinic in Hamburg and will be completed some time next year.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide linked to increased risk of severe eye condition NAION in new study